NORML

JANUARY 9, 2019

Today, the rollout of the new leadership team of the Congressional Cannabis Caucus was announced, with Representatives Barbara Lee (D-CA) and David Joyce (R-OH) joining founding members Earl Blumenauer (D-OR) and Don Young (R-AK). For far too long, communities of color and women have been left out of the conversation on cannabis.

Legislation 188

Legislation Policy Cannabis Programs 188

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. billion 1 by 2025.

Access 105

Access Research and Development Pharmaceutical Therapy 105

Cannabis Law Report

NOVEMBER 26, 2019

Dandapani writes … Cannabis, although an ancient plant tracing its origins back to over 12000 years ago, remains misunderstood in a “post-legalization” era. It was thus not surprising to see a lot of vendors at the Canadian Cannabis and Business Expo marketing cannabis “slim” foods and slimming pills made entirely of cannabis.

Chronic Pain 91

Chronic Pain Events THC Education 91

The Joint Blog

JULY 5, 2022

There’s no question that cannabis products can relieve pain , both physically and emotionally. But despite the global recession, the cannabis business appears to be booming, and along with it, owners are making a lot of money. But what other ways are cannabis businesses contributing to social justice causes and responsibility?

Business 26

Business Environment Programs Cannabis 26

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. a global leader in the cannabis industry serving both medical and consumer markets and dedicated to helping people improve their lives.

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Canna Law Blog

FEBRUARY 10, 2020

In the past year or so, we have seen a remarkable uptick in requests for advice and legal services related to the international cannabis trade. cannabis businesses; and. If you cannot attend, feel free to register anyway and submit questions prior to the event. Your questions. We hope to see you March 4!

Compliance 77

Compliance Compliance Hemp Events 77

Cannabis Law Report

JULY 27, 2021

–(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoid research, has appointed Nicolas Schlienz, Ph.D., The ORR is a web-based research platform open to adults and adult caregivers of dependents who are, or are considering, the use of cannabis or hemp products for therapeutic purposes.

Data 105

Data Epilepsy Research and Development Clinical Trials 105

The Cannigma

MAY 5, 2021

Considering what we do and don’t know, it would be remiss to not ask whether cannabis has the potential to provide relief. Because COVID is still so new, there are no studies in humans showing the utility cannabis to treat COVID or alleviate the symptoms of long COVID. What is long COVID? episodes per month. episodes per month.

Chronic Pain 144

Chronic Pain Research and Development Patients Treatment 144

Cannabis Law Report

AUGUST 27, 2021

The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future. Delic is focused on bringing psychedelic wellness to the mainstream.

Research and Development 98

Research and Development Treatment Media Medicine 98

Cannabis Law Report

SEPTEMBER 22, 2022

Acting in one fell swoop, on September 18, 2022, California Governor Gavin Newsom signed 10 cannabis-related legislative bills into law. Senate Bill 1326 is the most widely recognized bill of the group, and authorizes the Governor the power to sign cannabis trade agreements with other states where cannabis is legal.

Law 52

Law Events Packaging Pets 52

Canna Law Blog

NOVEMBER 17, 2021

It was the first conference for the ABA’s new Global Cannabis section and the first live event I’ve done since COVID started. The panel discussed “Legal Ethics in International Cannabis.” ” My colleague Adams Lee participated too, but on another panel covering the international cannabis trade.

Cannabis 76

Cannabis Banking Oil Treatment 76

Cannabis Law Report

JULY 22, 2021

Levitee has ambitious plans to advance its business following its recent successful listing on the Canadian Securities Exchange. Levitee has a well capitalized balance sheet with sufficient working capital to execute on future acquisitions, as well as ongoing business initiatives. About Levitee Labs.

eCommerce 105

eCommerce Therapy Media Access 105

Cannabis Law Report

JANUARY 12, 2022

(OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and development company, has closed the sale of its last remaining cannabis facility, completing a transition to the biopharmaceutical industry. “This is a landmark event for Gb Sciences,” said Chairman and CEO John Poss. In addition, Gb Sciences has 12 U.S.

Research and Development 52

Research and Development Clinical Trials Chronic Pain Therapy 52

MMJ Recs

DECEMBER 20, 2023

Virginia, once known for its conservative stance on cannabis, has made significant strides in embracing the medicinal properties of this plant. The establishment of medical marijuana dispensaries in Virginia represents a progressive approach to healthcare, offering patients alternative treatment options for various medical conditions.

Dispensary 52

Dispensary Marijuana Strains Patients 52

Canna Law Blog

JULY 3, 2023

As the cannabis economy tanks (with the exception of states that just came online for medical and/or adult-use), cannabis litigation is picking up. All cannabis entrepreneurs and businesses should be mindful of cannabis litigation trends, especially in these lean times.

Cannabis 58

Cannabis Business Legalization Recreational 58

Cannabis Law Report

AUGUST 17, 2021

.–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. We look forward to initiating our Phase 3 trial and adding to the body of evidence that supports ganaxolone’s potential as an innovative treatment option for rare epilepsies.”. Chief Medical Officer of Marinus. “We Data Highlights.

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Cannabis Law Report

JULY 24, 2021

This expansive patent would allow Mydecine to scale its coverage in drug development research in lieu of promising discoveries and FDA-approval progress for novel therapeutics, including granting Breakthrough Therapy Designation to MDMA for the treatment of PTSD in recent years. About Mydecine Innovations Group.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

Canna Law Blog

MAY 13, 2020

Unfortunately, COVID-19 has put the damper on watching live professional sports on TV, and clearly no one can attend any sporting events right now or likely anytime soon. So to maintain antiquated, punitive anti-cannabis consumption and/or business participation policies at the pro level seemed draconian and out of touch at best.

Consumption 67

Consumption Treatment Policy THC 67

Cannabis Law Report

JULY 24, 2021

BetterLife’s goal is to bring this treatment to the Investigational New Drug (“IND”) application and the clinic as soon as possible because it is non-addictive yet potentially highly effective. TD-010 is a treatment of anxiety without the addictive potential of benzodiazepines. Benzodiazepine Dependency. neuroscience. About Mitacs.

Research and Development 98

Research and Development Treatment Therapy Media 98

Veriheal

OCTOBER 4, 2022

Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) have treatment options, but currently, there is no effective cure. Brownie Mary, was an American medical cannabis activist and commonly associated with being an edibles pioneer. Brownie Mary and Her Significance to Cannabis Culture.

Wellness and Beauty 104

Wellness and Beauty Edibles Patients Cannabis 104

Cannabis Law Report

JULY 14, 2021

The exploratory trial was the latest of several small trials where ImmunoFlex has focused on analysing immune system modulation at a genomic level resulting from treatment with compounds including CBD, THC, NAC and several other widely available compounds. cannabis sector, real estate, and a consumer-targeted biotechnology venture.

Research and Development 105

Research and Development Clinical Trials Events Treatment 105

Cannabis Law Report

AUGUST 2, 2021

capital markets, negative global economic conditions, potential negative developments in our clinical trials or research programs, other negative developments in our business, or unfavorable legislative or regulatory developments. Any such forward-looking statements represent management’s estimates as of the date of this press release.

Clinical Trials 105

Clinical Trials Research and Development Treatment Conditions 105

Cannabis Law Report

JUNE 28, 2022

The Perils of Cannabis Transport Without Legal Advisement. The commercial regulated cannabis industry, which includes both industrial hemp and marijuana, is in its infancy. In addition, she was traveling in a jurisdiction that does not either allow for or has no real ability to test for, the presence of unlawful cannabis compounds.

Legalization 52

Legalization Supply Chain Hemp Cannabis 52

Cannabis Law Report

AUGUST 6, 2022

Over the past few years, August has become a popular month for cannabis industry reform in Massachusetts. 3096, earlier this week that significantly changed many of the challenges faced by operators in the Commonwealth’s cannabis market for years. Lauren Medeiros Forster. Most recently, the Massachusetts legislature approved a bill, S.

Cannabis 52

Cannabis Events Legislation Business 52

Cannabis Law Report

OCTOBER 20, 2021

The event will also feature a two-day pre-Summit Introductory Workshop Program (17-18 November) led by Nigel Denning, Dr Tra-ill Dowie with world-leading therapist trainer Dr Bill Richards (USA) from Johns Hopkins University. Here’s their full press release as a PDF.

Therapy 52

Therapy Medicine Topical Events 52

Cannabis Law Report

JULY 19, 2021

Our collaboration with the University of Milan is expected to afford us an incredible opportunity to, among other things, rigorously map out how cannabis strains behave throughout a full heat-not-burn temperature spectrum at incremental volumes inhaled,” said Jordan Medley, head of product operations at RYAH.

Therapy 76

Therapy Data Research and Development Events 76

Cannabis Law Report

JULY 7, 2021

We are fortunate to have a leadership team with great depth, decades of operating experience and detailed knowledge of our businesses. is a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments. The recent addition of KGK Science Inc. Twitter: @KetamineOne.

Research and Development 98

Research and Development Treatment Therapy Banking 98

Cannabis Law Report

JUNE 29, 2021

These actions will expand brand presence in both recreational cannabis and national CBD markets in North America, solidify sales and distribution, and streamline operations. Based in California, FeelWell’s flagship cannabis brand, CLIX , produces a variety of herbal blended pre-roll cannabis products, in addition to micro-dosed THC tablets.

CBD 95

CBD Events Recreational Cannabinoids 95

Cannabis Law Report

NOVEMBER 26, 2021

MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp. NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce it has entered into a definitive agreement with Canada-based Avaria Health & Beauty Corp.

Wellness and Beauty 52

Wellness and Beauty Supply Chain Research and Development Events 52

Cannabis Law Report

AUGUST 10, 2021

The global chronic pain treatment market is predicted to progress at a CAGR of 6.5% It is an honour and privilege to be in the position to use novel psychedelic treatments to solve the complex puzzle that is chronic pain. These statements relate to future events or future performance. billion in 2030. 3 Psychol Res Behav Manag.

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

Cannabis Law Report

AUGUST 3, 2021

TORONTO–( BUSINESS WIRE )– Cybin Inc. Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. The Neo Exchange Inc.

Clinical Trials 105

Clinical Trials Events Treatment Banking 105

Cannabis Law Report

APRIL 13, 2022

The Company aims to establish consistent quality control standards as more patients and clinicians incorporate psychedelic compounds into treatment plans. Delic Labs is also a leading cannabis analytical and research company boasting clients that include some of the largest brands in the world. About Delic Corp. About Delic Corp.

Research and Development 52

Research and Development Treatment Extraction Medicine 52

Veriheal

NOVEMBER 10, 2020

Cannabis legalization is a serious question that deserves serious answers. Both of these situations could be incredibly improved through positive cannabis reform and legalization. A Stroll Down New York’s Cannabis Lane. New York stands to do more than just improve its economy by legalizing cannabis.

Recreational 97

Recreational Legalization Cannabis Education 97

Cannabis Law Report

FEBRUARY 2, 2022

MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp. This application comes on the heels of Colombia’s new legislation requiring insurance companies to cover cannabis prescriptions. “I The research will look at all of the potential mechanisms of cannabinoids in preventing infection from the SARS-CoV-2 (COVID-19) virus.

Cannabinoids 52

Cannabinoids Clinical Trials Events Cultivation 52

Cannabis Law Report

JUNE 11, 2021

In turn, here are the top 6 questions we’ve been getting lately around ketamine clinics: Isn’t the regulation of ketamine clinics just like adult-use/medicinal cannabis businesses? Pursuant to the federal Controlled Substances Act, cannabis is an illegal schedule I controlled substance while ketamine is on schedule III.

Law 104

Law Compliance Compliance DEA 104

Cannabis Law Report

JULY 28, 2021

InnarisBio), to develop a novel sol-gel intranasal drug delivery technology to improve treatments for mental health disorders. InnarisBio aims to be a revolutionary technology company for intranasal drug delivery in the treatment of CNS disorders. A potential solution is direct nose-to-brain delivery. About atai Life Sciences.

Research and Development 98

Research and Development Programs Treatment Media 98